help  | faq  | software  | BAR

Publication : Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.

First Author  Assi R Year  2018
Journal  Cancer Volume  124
Pages  2758-2765 PubMed ID  29660836
Issue  13
Paste the following link
Lists
This Publication isn't in any lists. Upload a list.

12 Authors

1 Entities

Trail: Publication





BAR logo CAGEF logo CAGEF logo Araport logo JCVI logo TACC logo

InterMine is funded by the and interoperation is funded by

© 2002 - 2021 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom